Journal article
Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
Gene expression, Vol.21(2), pp.34-40
12/01/2022
DOI: 10.14218/GE.2022.00016
Abstract
Primary biliary cholangitis (PBC) is an organ-specific chronic autoimmune disease characterized by T-lymphocyte mediated destruction of intrahepatic biliary epithelial cells due to a combination of genetic and possible environmental factors. PBC progresses to hepatic fibrosis and cirrhosis, with the potential of developing hepatocellular carcinoma (HCC) if left untreated. PBC is more common in middle-aged women. It is diagnosed in patients with elevated liver enzymes and the serological hallmark of antimitochondrial antibody (AMA). Early diagnosis and treatment are crucial in improving survival and preventing long-term complications of liver disease. Ursodeoxycholic acid (UDCA) is first-line treatment for PBC. Obeticholic acid (OCA) and fibrates, in combination with UDCA or as monotherapy, may be given to PBC patients with partial or no UDCA response. Liver transplantation has thus been indicated in patients with decompensated cirrhosis or unresectable HCC.
Details
- Title: Subtitle
- Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
- Creators
- Badi Rawashdeh - NHS Blood and TransplantAllison Couillard - NHS Blood and TransplantAasem RawshdehHassan Aziz - NHS Blood and TransplantJames EstebanMotaz Selim - NHS Blood and Transplant
- Resource Type
- Journal article
- Publication Details
- Gene expression, Vol.21(2), pp.34-40
- Publisher
- Xia & He Publishing
- DOI
- 10.14218/GE.2022.00016
- ISSN
- 1052-2166
- eISSN
- 1555-3884
- Language
- English
- Date published
- 12/01/2022
- Academic Unit
- Surgery
- Record Identifier
- 9984701645802771
Metrics
1 Record Views